Endocarditis infecciosa
- Martínez Monzonís, Amparo
- Abu Assi, Emad
- Raposeiras Roubín, Sergio
- Vega Fernández, J. M.
ISSN: 0304-5412
Year of publication: 2013
Series: 11
Issue: 41
Pages: 2465-2478
Type: Article
More publications in: Medicine: Programa de Formación Médica Continuada Acreditado
Abstract
Infective endocarditis still remains a severe disease with high morbimortality rates despite substantial improvements have been made in antibiotic therapy and surgical management. Epidemiological features of infective endocarditis have changed during the last years because of an increase in the age of the patients and comorbidities accompanying the elderly. Further more, nosocomial and staphylococcal endocarditis have risen significantly. Prosthetic valve endocarditis is a serious condition whose incidence has increased in recent years. Diagnosis basis of infectious endocarditis is the modified Duke criteria, being the microbiological techniques and echocardiography the most relevant. Treatment is done with antibiotics and surgery is indicated according to the clinical evolution. Antibiotic prophylaxis has undergone major changes in recent years. These changes are intended to define more clearly when infective endocarditis prophylaxis is or is not recommended.
Bibliographic References
- Baddour LM, Epstein AE, Erickson CC, Knight BP, Levinson ME, Lockhart PB. Update on cardiovascular implantable electronic device infections and their management: a scientificif statement from the American heart association. Circ. 2010;121:458-77.
- Bonow RO, Carabello BA, Chatterjee K, de Leon AC Jr, Faxon DP, Freed MD. 2008 Focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients withvalvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines: endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. Circulation. 2008;118(15):e523-661.
- Fernández AL, Varela E, Martínez L, Martínez A, Sierra J, González-Juanatey JR. Evaluation of a multiplex real time PCR assay for detecting patogens in cardiac valve tissue in patients with endocarditis. Rev Esp Cardiol. 2010; 63:1205-8.
- Fernández-Hidalgo N, Almirante B, Tornos P, González-Alujas MT, Planes AM, Galiñanes M. Inmediate and long term outcome of left sided infectiveendocarditis. A 12 year prospective study from a contemporarycohort in a referral hospital. Clin Microbiol Infect. 2012;18:e522-30.
- Habib G, Hoen B, Tornos P, Thuny F, Predengast B, Vilacosta I. Guías de práctica clínica para prevención, diagnóstico y tratamiento de la endocarditis infecciosa (nueva versión 2009). Rev Esp Cardiol. 2009;62(12):1465.e1-54.
- Hoen B, Duval X. Infective endocarditis. N Engl J Med. 2013;368:1425-33.
- Kang DH, Kim YJ, Kim SH, Sun BJ, Kim DH, Yun SC. Early surgery versus conventional treatment for infective endocarditis. N Engl J Med. 2012;366:2466-73.
- Katsouli A, Massad MG. Current issues in the diagnosis and management of blood culture negative infective and non infective endocarditis. Ann Thorac Surg. 2013;95:1467-74.
- Thuny F, Grisoli D, Collart F, Habbib G, Raoult D. Manegement of infectice endocarditis: Challenges and perspectives. Lancet. 2012;379:965-75.
- Vahanian A, Alfieri O, Andreotti F, Antunes MJ, Barón-Esquivias G, Baumgartner H. Guidelines on the management of valvular heart disease (version 2012). Eur Heart J. 2012;33(19):2451-96.
- Wilson W, Taubert KA, Gewith M, Lockhart PB, Baddour PB, Levinson M. Prevention on infective endocarditis. Guidelines of the American Heart Association. A guideline from The American Herat Association Rheumatic Fever, endocarditis and Kawasaky Disease Committee, council on Cardiovascular Disease in the Young and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anhestesia, and the Quality of Care and Outcomes Re-search Interdisciplinary working Group. Circ. 2007;116:1736-54.